These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 29581084)
1. Beyond the five-year horizon: long-term outcome of high-risk and inoperable patients undergoing TAVR with first-generation devices. Deutsch MA; Erlebach M; Burri M; Hapfelmeier A; Witt OG; Ziegelmueller JA; Wottke M; Ruge H; Krane M; Piazza N; Bleiziffer S; Lange R EuroIntervention; 2018 May; 14(1):41-49. PubMed ID: 29581084 [TBL] [Abstract][Full Text] [Related]
2. Analysis of cardiovascular mortality, bleeding, vascular and cerebrovascular events in patients with atrial fibrillation vs. sinus rhythm undergoing transfemoral Transcatheter Aortic Valve Implantation (TAVR). Herold J; Herold-Vlanti V; Sherif M; Luani B; Breyer C; Bonaventura K; Braun-Dullaeus R BMC Cardiovasc Disord; 2017 Dec; 17(1):298. PubMed ID: 29262768 [TBL] [Abstract][Full Text] [Related]
3. Acute and 30-Day Outcomes in Women After TAVR: Results From the WIN-TAVI (Women's INternational Transcatheter Aortic Valve Implantation) Real-World Registry. Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail GW; Sharma S; Ferrer MC; Naber C; Kievit P; Faggioni M; Snyder C; Morice MC; Mehran R; JACC Cardiovasc Interv; 2016 Aug; 9(15):1589-600. PubMed ID: 27491609 [TBL] [Abstract][Full Text] [Related]
4. Prospective comparison between three TAVR devices: ACURATE neo vs. CoreValve vs. SAPIEN XT. A single heart team experience in patients with severe aortic stenosis. Jatene T; Castro-Filho A; Meneguz-Moreno RA; Siqueira DA; Abizaid AAC; Ramos AIO; Arrais M; Le Bihan DCS; Barretto RBM; Moreira AC; Sousa AGMR; Eduardo Sousa J Catheter Cardiovasc Interv; 2017 Jul; 90(1):139-146. PubMed ID: 28029207 [TBL] [Abstract][Full Text] [Related]
6. Prevalence and Impact of Atrial Fibrillation in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: An Analysis From the SOURCE XT Prospective Multicenter Registry. Tarantini G; Mojoli M; Windecker S; Wendler O; Lefèvre T; Saia F; Walther T; Rubino P; Bartorelli AL; Napodano M; D'Onofrio A; Gerosa G; Iliceto S; Vahanian A JACC Cardiovasc Interv; 2016 May; 9(9):937-46. PubMed ID: 27085579 [TBL] [Abstract][Full Text] [Related]
7. The Incidence and Predictors of Early- and Mid-Term Clinically Relevant Neurological Events After Transcatheter Aortic Valve Replacement in Real-World Patients. Bosmans J; Bleiziffer S; Gerckens U; Wenaweser P; Brecker S; Tamburino C; Linke A; J Am Coll Cardiol; 2015 Jul; 66(3):209-217. PubMed ID: 26184612 [TBL] [Abstract][Full Text] [Related]
8. Outcomes of Redo Transcatheter Aortic Valve Replacement for the Treatment of Postprocedural and Late Occurrence of Paravalvular Regurgitation and Transcatheter Valve Failure. Barbanti M; Webb JG; Tamburino C; Van Mieghem NM; Makkar RR; Piazza N; Latib A; Sinning JM; Won-Keun K; Bleiziffer S; Bedogni F; Kapadia S; Tchetche D; Rodés-Cabau J; Fiorina C; Nombela-Franco L; De Marco F; de Jaegere PP; Chakravarty T; Vaquerizo B; Colombo A; Svensson L; Lange R; Nickenig G; Möllmann H; Walther T; Della Rosa F; Elhmidi Y; Dvir D; Brambilla N; Immè S; Sgroi C; Gulino S; Todaro D; Pilato G; Petronio AS; Tamburino C Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27578840 [TBL] [Abstract][Full Text] [Related]
9. Long-term results and durability of the CoreValve transcatheter aortic bioprosthesis: outcomes beyond five years. Panico RA; Giannini C; De Carlo M; Angelillis M; Spontoni P; Pieroni A; Costa G; Bertini P; Guarracino F; Petronio AS EuroIntervention; 2019 Mar; 14(16):1639-1647. PubMed ID: 30561369 [TBL] [Abstract][Full Text] [Related]
11. Incidence, Predictors, and Clinical Impact of Prosthesis-Patient Mismatch Following Transcatheter Aortic Valve Replacement in Asian Patients: The OCEAN-TAVI Registry. Miyasaka M; Tada N; Taguri M; Kato S; Enta Y; Otomo T; Hata M; Watanabe Y; Naganuma T; Araki M; Yamanaka F; Shirai S; Ueno H; Mizutani K; Tabata M; Higashimori A; Takagi K; Yamamoto M; Hayashida K; JACC Cardiovasc Interv; 2018 Apr; 11(8):771-780. PubMed ID: 29673509 [TBL] [Abstract][Full Text] [Related]
12. Procedural and 30-day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study. Montone RA; Testa L; Fraccaro C; Montorfano M; Castriota F; Nerla R; Angelillis M; Tusa M; Giannini F; Garatti A; Tarantini G; Petronio AS; Brambilla N; Bedogni F Catheter Cardiovasc Interv; 2017 Dec; 90(7):1206-1211. PubMed ID: 28145039 [TBL] [Abstract][Full Text] [Related]
13. Insights on mid-term TAVR performance: 3-year clinical and echocardiographic results from the CoreValve ADVANCE study. Bleiziffer S; Bosmans J; Brecker S; Gerckens U; Wenaweser P; Tamburino C; Linke A; Clin Res Cardiol; 2017 Oct; 106(10):784-795. PubMed ID: 28484830 [TBL] [Abstract][Full Text] [Related]
19. Neurological Events Following Transcatheter Aortic Valve Replacement and Their Predictors: A Report From the CoreValve Trials. Kleiman NS; Maini BJ; Reardon MJ; Conte J; Katz S; Rajagopal V; Kauten J; Hartman A; McKay R; Hagberg R; Huang J; Popma J; Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27601429 [TBL] [Abstract][Full Text] [Related]
20. Clinical Outcomes Following Transcatheter Aortic Valve Replacement in Asian Population. Yoon SH; Ahn JM; Hayashida K; Watanabe Y; Shirai S; Kao HL; Yin WH; Lee MK; Tay E; Araki M; Yamanaka F; Arai T; Lin MS; Park JB; Park DW; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Muramatsu T; Hanyu M; Kozuma K; Kim HS; Saito S; Park SJ; JACC Cardiovasc Interv; 2016 May; 9(9):926-33. PubMed ID: 27151607 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]